Feedback
  • Article / Essay
  • Commentary: Adverse event profiles of PARP inhibitors: analysis of spontaneous…

Commentary: Adverse event profiles of PARP inhibitors: analysis of spontaneous reports submitted to FAERS

Affiliation
GSK ,Philadelphia ,PA ,United States
Schilder, Jeanne M.;
Affiliation
GSK ,Durham ,NC ,United States
Golembesky, Amanda;
Affiliation
GSK ,Collegeville ,PA ,United States
Boyle, Tirza Areli Calderón;
Affiliation
GSK ,Collegeville ,PA ,United States
Ye, Gui Lan;
Affiliation
GSK ,Collegeville ,PA ,United States
Kuplast, Judi

Preview

Category

Published in:
Frontiers in Pharmacology  
Vol. 14 (16.08.2023)
Volume:
14
Date Issued:
16.08.2023
DOI:
10.3389/fphar.2023.1241524
Language:
English
Type of Resource:
Text
Keywords:
niraparib; PARP inhibitors; pharmacovigilance; FAERS; lymphangioleiomyomatosis
DDC subject of DNB:
610 Medical sciences Medicine

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:
open graphic

Rights

License Holder: Copyright © 2023 Schilder, Golembesky, Boyle, Ye and Kuplast.

Use and reproduction: